Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2006
04/13/2006US20060078966 IL-17 receptor like polypeptides and uses thereof
04/13/2006US20060078965 Chinese hamster ovary cell line transfected with 30K gene
04/13/2006US20060078964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/13/2006US20060078963 Methods for producing modified glycoproteins
04/13/2006US20060078962 Chitosan bound to residues of one or more polypeptides, at least one which has a tyrosine or glutamine residue; formed by reacting the peptides, chitosan and a transglutaminase or tyrosinase enzyme and allowing the chitosan to bind to the peptides; used for dressing wounds
04/13/2006US20060078959 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers
04/13/2006US20060078952 Method for identifying antimicrobial molecules which interfere with apolipoprotein N-acyltransferase activity
04/13/2006US20060078946 Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody
04/13/2006US20060078944 Methods and reagents relating to inflammation and apoptosis
04/13/2006US20060078942 Method of treatment using interferon-tau
04/13/2006US20060078933 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
04/13/2006US20060078932 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
04/13/2006US20060078922 Novel purified polypeptides from haemophilus influenzae
04/13/2006US20060078907 Nanomachine compositions and methods of use
04/13/2006US20060078901 Listeria monocytogenes genome, polypeptides and uses
04/13/2006US20060078892 Enzyme resistance; chromatography; bovine spongiform encephalopathy
04/13/2006US20060078884 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
04/13/2006US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
04/13/2006US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription
04/13/2006US20060078564 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
04/13/2006US20060078562 RAGE fusion proteins and methods of use
04/13/2006US20060078553 Diverse multi-unit complexes including a tRNA synthetase fragment
04/13/2006US20060078550 Porcine fgl2
04/13/2006US20060078539 Remedies for tumor in hematopoietic organs
04/13/2006US20060078537 Mono-and dual chemokine/cytokine constructs
04/13/2006CA2583220A1 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes
04/13/2006CA2580967A1 Irta-4 antibodies and their uses
04/13/2006CA2580515A1 Expression system, components thereof and methods of use
04/13/2006CA2579845A1 Devices and methods for integrated continuous manufacturing of biological molecules
04/12/2006EP1645631A2 Neisseria antigens and compositions
04/12/2006EP1645629A1 Human osteoclast-specific and related genes
04/12/2006EP1645285A2 Therapeutical use of anti-mag antibody for the treatment of ischemic stroke
04/12/2006EP1645183A1 Process for producing human-origin immunocompetent cell
04/12/2006EP1644738A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
04/12/2006EP1644477A2 Polynucleotides encoding novel adiponectin receptor variants
04/12/2006EP1644409A1 Complement depletion using recombinant human c3-derivatives
04/12/2006EP1644403A2 Cytotoxic depsipeptides
04/12/2006EP1644039A2 Compositions and methods for treating coagulation related disorders
04/12/2006EP1463807A4 Pichia pastoris formate dehydrogenase and uses therefor
04/12/2006EP1373524B1 Cytomegalovirus intron a fragments
04/12/2006EP1192247B1 Sphingosine kinase enzyme
04/12/2006EP1140175B1 Antibodies to truncated vegf-d and uses thereof
04/12/2006EP1003868B1 Wheat rht gene for genetic control of plant growth and development
04/12/2006EP1000150B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
04/12/2006EP0972042B1 Polypeptide expressed in the horny layer of epidermis and use thereof
04/12/2006EP0877547B1 Plant glutamate receptors
04/12/2006EP0861319B1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx
04/12/2006EP0675959B1 Dna amplification
04/12/2006EP0491824B2 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
04/12/2006CN1759186A Purification of polypeptides
04/12/2006CN1759121A Purification process for bacterial cytolysin
04/12/2006CN1757745A Method of high efficiency expression tPA exogenic protein using methanol yeast system and its purification preparation technology of expressed product
04/12/2006CN1757724A Use of multiple recombination sites with unique specificity in recombinational cloning
04/12/2006CN1757723A Method of producing recombination human bone morphopoiesis protein
04/12/2006CN1250738C General means of labeling protein by using wheat embryo cell-free protein synthesis system
04/12/2006CN1250729C A method of extracellular production of target proteins employing OmpF in e coli
04/12/2006CN1250728C Method for generating active isdime AMV-RT in procaryotic cell
04/12/2006CN1250727C Pesticidal fusions
04/12/2006CN1250725C Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
04/12/2006CN1250723C Genetic control of plant growth and development
04/12/2006CN1250722C Method for secretion and prodn. of protein
04/12/2006CN1250721C Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
04/12/2006CN1250719C Noninvasive detection of colorectal cancer and other gasrointestinal pathology
04/12/2006CN1250707C High-yield bacterial strain C-1027-20 for preparing Lidamycin as antineoplastic antibiotic
04/12/2006CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms
04/12/2006CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis
04/11/2006USRE39062 Cell proliferation; cell differentiation; Dna libraries; screening genes
04/11/2006US7026524 Human coagulation factor VII variants
04/11/2006US7026463 Lactobacillus enzymes for improving flavor and fermentation characteristics in fermented dairy products such as cheese and yogurt; immunostimulants
04/11/2006US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
04/11/2006US7026455 Anti-pro 1343 antibodies
04/11/2006US7026453 Method of protein purification
04/11/2006US7026452 Human mitochondrial proteins and polynucleotides encoding the proteins
04/11/2006US7026451 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
04/11/2006US7026449 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/11/2006US7026445 Human SDF-5 protein and compositions
04/11/2006US7026157 Bacterial hemoglobin receptor genes
04/11/2006US7026152 Synergistic degradation of oligosaccharides by endoglucanases, resulting in the production of ethanol from complex cellulose substrates; bioethanol
04/11/2006US7026147 α-2,3-Sialyltransferase polypeptides
04/11/2006US7026140 Serum paraoxonase
04/11/2006US7026139 To regulate an immune response in an animal
04/11/2006US7026134 Contacting the sample with the conjugate and an antibody capable of binding atleast one epitope of oxycodone and its metabolite, and detecting the bound conjugate
04/11/2006US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound
04/11/2006US7026129 IG lambda biopolymer markers predictive of Alzheimers disease
04/11/2006US7026128 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander
04/11/2006US7026127 Reg-like protein
04/11/2006US7026125 formed by culturing a host cell expressing both receptors; screening a ligand for its effect on an activity of a retinoid X receptor (RXR) hormone receptor heterodimer; heterodimer amplifys the activity of the hormone receptor
04/11/2006US7026123 UTR tag assay for gene function discovery
04/11/2006CA2204375C Methods for the diagnosis of glaucoma
04/06/2006WO2006036922A2 Srage mimetibody, compositions, methods and uses
04/06/2006WO2006036878A2 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
04/06/2006WO2006036745A2 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
04/06/2006WO2006035741A1 Gene expressed specifically in es cells and utilization of the same
04/06/2006WO2006035687A1 Method of constructing transgenic bird
04/06/2006WO2006035057A1 Modified proteins
04/06/2006WO2005113592A3 Interferon-alpha polypeptides and conjugates
04/06/2006WO2005111081A3 Immunoglobulin-like variable chain binding polypeptides and methods of use
04/06/2006WO2004029220A3 Synthetic genes
04/06/2006WO2004009838A3 H. Pylori FUCOSYLTRANSFERASES
04/06/2006US20060075519 Polypeptides having cellobiase activity and ploynucleotides encoding same